TAOX · TAO Synergies Inc. · Executive Compensation
Market Cap
$24.69M
Shares
7.48M
Volume · Oct 23
21.93K
Avg daily vol (3M)
165.49K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Robert Weinstein | CFO Secretary and Executive Vice President | $883,344 |
| Daniel L. Alkon MD | President and CSO | $812,461 |
| Dr. Alan J. Tuchman | Chief Executive Officer | $749,642 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Daniel L. Alkon MD | President and CSO | $1,496,028 |
| Robert Weinstein | CFO Secretary and Executive Vice President | $1,184,751 |
| Dr. Alan J. Tuchman | Chief Executive Officer | $1,067,899 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Robert Weinstein | CFO, Secretary and Executive Vice President | $616,064 |
| Daniel L. Alkon MD | President and CSO | $335,976 |
| Dr. Alan J. Tuchmam | Chief Executive Officer | $184,375 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Charles S. Ryan | Former CEO | $1,467,806 |
| Daniel L. Alkon MD | President and CSO | $801,056 |
| Robert Weinstein | CFO, Secretary and Executive Vice President | $511,495 |
| Dr. Alan J. Tuchmam | Chief Executive Officer | $35,625 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Bruce T. Bernstein | director | Appointed | 2025-12-19 |
| Robert Ephron | the Board | Appointed | 2025-08-29 |
| Alan Tuchman | member of the Board | Resigned | 2025-08-29 |
| Jonathan Schechter | member of the board of directors | Resigned | 2025-08-29 |
| Dr. Alan J. Tuchman, M.D. | Chief Executive Officer | Resigned | 2025-06-27 |
| Dr. Daniel L. Alkon, M.D. | member of its Board of Director and any and all committees thereof | Resigned | 2025-06-09 |
| Dr. Daniel L. Alkon, M.D. | President and Chief Scientific Officer | Resigned | 2025-06-09 |
| Alan J. Tuchman | Chief Medical Officer | Appointed | 2025-06-09 |
| Joshua Silverman | Executive Chairman | Appointed | 2025-06-09 |
| Alan J. Tuchman | director | Resigned | 2025-06-09 |
| Alan J. Tuchman | Chief Executive Officer | Resigned | 2025-06-09 |
| Daniel L. Alkon | director | Resigned | 2025-06-09 |
| Daniel L. Alkon | Director | Appointed | 2023-12-21 |
| Alan Tuchman | Director | Appointed | 2023-12-21 |
| Jonathan L. Schechter | Director | Appointed | 2022-10-13 |
| Bruce T. Bernstein | Director | Appointed | 2022-10-13 |
Leadership
- Dr. Alan J. Tuchman CEO
- Bruce T. Bernstein Chairman
- Joshua N. Silverman Chairman
- Joshua Silverman Chairman
- Robert Weinstein CFO
- Alan Tuchman Board Member
- Daniel L. Alkon Board Member
- Jonathan L. Schechter Board Member
- Robert Ephron Board Member
- William S. Singer Board Member